LANDOS BIOPHARMA INC (LABP) Forecast, Price Target & Analyst Ratings

NASDAQ:LABP • US5150692011

Current stock price

22.93 USD
+0.13 (+0.58%)
At close:
22.91 USD
-0.02 (-0.09%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LANDOS BIOPHARMA INC (LABP).

Forecast Snapshot

Consensus Price Target

Price Target
$12.96
-43.46% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 7, 2024
Period
Q2 / 2024
EPS Estimate
-$0.89
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
47.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$12.96
Upside
-43.46%
From current price of $22.93 to mean target of $12.96, Based on 8 analyst forecasts
Low
$5.05
Median
$12.96
High
$21.44

Price Target Revisions

1 Month
0.00%
3 Months
154.20%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for LABP. The average price target is 12.96 USD. This implies a price decrease of -43.46% is expected in the next year compared to the current price of 22.93.
The average price target has been revised upward by 154.2% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LABP Current Analyst RatingLABP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

LABP Historical Analyst RatingsLABP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
47.50%
LABP was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about LABP.
In the previous month the buy percentage consensus was at a similar level.
LABP was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-04-01HC Wainwright & Co.Downgrade Buy -> Neutral
2023-01-06JefferiesDowngrade Hold -> Underperform
2022-11-11SVB LeerinkMaintains Market Perform
2022-08-12SVB LeerinkMaintains Market Perform
2022-08-12Raymond JamesDowngrade Outperform -> Market Perform
2022-04-12JefferiesDowngrade Buy -> Hold
2022-01-03JP MorganMaintains Neutral
2021-11-16SVB LeerinkDowngrade Outperform -> Market Perform
2021-10-20Craig-HallumInitiate Buy
2021-10-19HC Wainwright & Co.Initiate Buy
2021-09-23JonesTradingInitiate Buy
2021-07-30Raymond JamesMaintains Outperform
2021-03-01SVB LeerinkInitiate Outperform
2021-03-01Raymond JamesMaintains Outperform
2021-03-01JP MorganInitiate Neutral
2021-03-01JefferiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 7, 2024
Period
Q2 / 2024
EPS Estimate
-$0.89
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-41.67%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
4.37%

Next Earnings Summary

LABP is expected to report earnings on 8/7/2024. The consensus EPS estimate for the next earnings is -0.89 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
LABP revenue by date.LABP revenue by date.
18M
-100.00%
EBITDA
YoY % growth
LABP ebitda by date.LABP ebitda by date.
-13.19M
-67.81%		-30.54M
-131.54%		-38.62M
-26.46%		-44.778M
-2.74%		-22.746M
42.72%		-33.66M
-48.11%		-45.084M
-33.94%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
LABP ebit by date.LABP ebit by date.
-13.29M
-67.38%		-30.68M
-130.85%		-38.82M
-26.53%		-43.478M
-3.71%		-22.593M
43.55%		-28.203M
-24.09%		-47.583M
-68.72%		-90.168M
-89.50%		-32.64M
63.80%		-32.64M-32.64M-32.64M
Operating Margin
LABP operating margin by date.LABP operating margin by date.
N/AN/A-215.67%N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
LABP eps by date.LABP eps by date.
N/AN/AN/A
57.35%		-10.33
-8.56%		-3.49
64.69%		-2.23
35.44%		-1.72
23.06%		-1.21
29.38%		N/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.89
-41.67%		-0.82
13.19%		-0.44
55.70%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		-6.936M
-56.22%		-7.191M
-38.29%		-7.548M
-14.19%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LABP Yearly Revenue VS EstimatesLABP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 5M 10M 15M
LABP Yearly EPS VS EstimatesLABP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -5 -10 -15 -20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
18.15%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LANDOS BIOPHARMA INC / LABP Forecast FAQ

What do analysts expect the price target to be for LANDOS BIOPHARMA INC (LABP)?

8 analysts have analysed LABP and the average price target is 12.96 USD. This implies a price decrease of -43.46% is expected in the next year compared to the current price of 22.93.

What is the next earnings date for LABP stock?

LANDOS BIOPHARMA INC (LABP) will report earnings on 2024-08-07, before the market open.

What are the consensus estimates for LABP stock next earnings?

The consensus EPS estimate for the next earnings of LANDOS BIOPHARMA INC (LABP) is -0.89 USD and the consensus revenue estimate is 0 USD.

Can you provide the analyst count for LANDOS BIOPHARMA INC stock?

The number of analysts covering LANDOS BIOPHARMA INC (LABP) is 8.